N-acetylcysteine augmentation therapy for moderate-to-severe obsessive-compulsive disorder: randomized, double-blind, placebo-controlled trial. (Q53162022)
Jump to navigation
Jump to search
scientific article published on 2 March 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | N-acetylcysteine augmentation therapy for moderate-to-severe obsessive-compulsive disorder: randomized, double-blind, placebo-controlled trial. |
scientific article published on 2 March 2016 |
Statements
N-acetylcysteine augmentation therapy for moderate-to-severe obsessive-compulsive disorder: randomized, double-blind, placebo-controlled trial. (English)
1 reference
K Paydary
1 reference
A Akamaloo
1 reference
A Ahmadipour
1 reference
F Pishgar
1 reference
S Emamzadehfard
1 reference
S Akhondzadeh
1 reference
2 March 2016
1 reference
41
1 reference
2
1 reference
214-219
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference